380 related articles for article (PubMed ID: 9374572)
1. Exudative lung injury is associated with decreased levels of surfactant proteins in a rat model of meconium aspiration.
Cleary GM; Antunes MJ; Ciesielka DA; Higgins ST; Spitzer AR; Chander A
Pediatrics; 1997 Dec; 100(6):998-1003. PubMed ID: 9374572
[TBL] [Abstract][Full Text] [Related]
2. Surfactant and surfactant inhibitors in meconium aspiration syndrome.
Dargaville PA; South M; McDougall PN
J Pediatr; 2001 Jan; 138(1):113-5. PubMed ID: 11148523
[TBL] [Abstract][Full Text] [Related]
3. Treatment of meconium aspiration syndrome with surfactant lavage in an experimental rabbit model.
Ohama Y; Ogawa Y
Pediatr Pulmonol; 1999 Jul; 28(1):18-23. PubMed ID: 10406046
[TBL] [Abstract][Full Text] [Related]
4. Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide is associated with suppression of nuclear transcription factor kappa B.
Hu X; Cao L; Lam LK; Zhu L; Guo C; Sun B
Biol Neonate; 2005; 87(2):73-81. PubMed ID: 15692188
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of high-frequency ventilation and surfactant treatment in experimental meconium aspiration syndrome.
Calkovska A; Sun B; Curstedt T; Renheim G; Robertson B
Acta Anaesthesiol Scand; 1999 Feb; 43(2):135-45. PubMed ID: 10027019
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory treatment in dysfunction of pulmonary surfactant in meconium-induced acute lung injury.
Mokra D; Drgova A; Kopincova J; Pullmann R; Calkovska A
Adv Exp Med Biol; 2013; 756():189-96. PubMed ID: 22836635
[TBL] [Abstract][Full Text] [Related]
7. Effects of a recombinant surfactant protein-C-based surfactant on lung function and the pulmonary surfactant system in a model of meconium aspiration syndrome.
Hilgendorff A; Doerner M; Rawer D; Leick J; Trotter A; Ebsen M; Ruppert C; Günther A; Gortner L; Reiss I
Crit Care Med; 2006 Jan; 34(1):203-10. PubMed ID: 16374175
[TBL] [Abstract][Full Text] [Related]
8. Exogenous surfactant improves lung compliance and oxygenation in adult rats with meconium aspiration.
Sun B; Herting E; Curstedt T; Robertson B
J Appl Physiol (1985); 1994 Oct; 77(4):1961-71. PubMed ID: 7836224
[TBL] [Abstract][Full Text] [Related]
9. Effects of surfactant/budesonide therapy on oxidative modifications in the lung in experimental meconium-induced lung injury.
Mikolka P; Kopincova J; Tomcikova Mikusiakova L; Kosutova P; Antosova M; Calkovska A; Mokra D
J Physiol Pharmacol; 2016 Feb; 67(1):57-65. PubMed ID: 27010895
[TBL] [Abstract][Full Text] [Related]
10. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome.
Salvesen B; Curstedt T; Mollnes TE; Saugstad OD
Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240
[TBL] [Abstract][Full Text] [Related]
11. Effects of Surfactant Lavage Combined With Intratracheal Budesonide Instillation on Meconium-Injured Piglet Lungs.
Lin CH; Jeng MJ; Kuo BI; Kou YR
Pediatr Crit Care Med; 2016 Jun; 17(6):e287-95. PubMed ID: 27124561
[TBL] [Abstract][Full Text] [Related]
12. Pneumocystis carinii pneumonia alters expression and distribution of lung collectins SP-A and SP-D.
Atochina EN; Beck JM; Scanlon ST; Preston AM; Beers MF
J Lab Clin Med; 2001 Jun; 137(6):429-39. PubMed ID: 11385364
[TBL] [Abstract][Full Text] [Related]
13. Alteration of surfactant proteins A and D in bronchoalveolar lavage fluid of Pneumocystis carinii pneumonia.
Qu J; He L; Rong Z; Pan J; Chen X; Morrison DC; Li X
Chin Med J (Engl); 2001 Nov; 114(11):1143-6. PubMed ID: 11729507
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice.
Beers MF; Atochina EN; Preston AM; Beck JM
J Lab Clin Med; 1999 May; 133(5):423-33. PubMed ID: 10235125
[TBL] [Abstract][Full Text] [Related]
15. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
16. Surfactant use for neonatal lung injury: beyond respiratory distress syndrome.
Finer NN
Paediatr Respir Rev; 2004; 5 Suppl A():S289-97. PubMed ID: 14980286
[TBL] [Abstract][Full Text] [Related]
17. Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis.
Honda Y; Takahashi H; Shijubo N; Kuroki Y; Akino T
Chest; 1993 Feb; 103(2):496-9. PubMed ID: 8432143
[TBL] [Abstract][Full Text] [Related]
18. Human surfactant protein a suppresses T cell-dependent inflammation and attenuates the manifestations of idiopathic pneumonia syndrome in mice.
Yang S; Milla C; Panoskaltsis-Mortari A; Ingbar DH; Blazar BR; Haddad IY
Am J Respir Cell Mol Biol; 2001 May; 24(5):527-36. PubMed ID: 11350821
[TBL] [Abstract][Full Text] [Related]
19. Surfactant phospholipids, surfactant proteins, and inflammatory markers during acute lung injury in children.
Todd DA; Marsh MJ; George A; Henderson NG; Barr H; Sebastian S; Clark GT; Koster G; Clark HW; Postle AD
Pediatr Crit Care Med; 2010 Jan; 11(1):82-91. PubMed ID: 19550365
[TBL] [Abstract][Full Text] [Related]
20. [Protective effects and mechanisms of recombinant human superoxide dismutase in acute lung injury of rats following meconium aspiration].
Lu MP; Du LZ; Yu ZZ; Chen XX
Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):777-81. PubMed ID: 16221352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
